New anticoagulant and antiplatelet agents: A primer for the gastroenterologist

Todd H. Baron, Patrick Sequeira Kamath, Robert D. McBane

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

A large number of patients worldwide receive anticoagulant and antiplatelet agents, collectively known as antithrombotic agents. Several new anticoagulants and antiplatelet agents recently were approved for use. Gastroenterologists may be unfamiliar with the mechanism of action, indications for use, and pharmacokinetics of these newer drugs. In patients undergoing elective and urgent endoscopic procedures, clinicians must be familiar with these medications to optimize outcomes. When the decision is made to continue the newer antithrombotic agents for elective procedures, the clinician must understand the risk that these agents may impart on procedural-induced bleeding. Finally, it is important to understand how to manage these agents in the presence of acute gastrointestinal bleeding. In this article the use of newer antithrombotic agents is reviewed.

Original languageEnglish (US)
Pages (from-to)187-195
Number of pages9
JournalClinical Gastroenterology and Hepatology
Volume12
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Fibrinolytic Agents
Platelet Aggregation Inhibitors
Anticoagulants
Hemorrhage
Pharmacokinetics
Pharmaceutical Preparations
Gastroenterologists

Keywords

  • Anticoagulants/Administration and dosage
  • Atrial fibrillation
  • Drug administration schedule
  • Drug monitoring
  • Endoscopy
  • Gastrointestinal
  • Thrombosis/Drug therapy

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

New anticoagulant and antiplatelet agents : A primer for the gastroenterologist. / Baron, Todd H.; Kamath, Patrick Sequeira; McBane, Robert D.

In: Clinical Gastroenterology and Hepatology, Vol. 12, No. 2, 02.2014, p. 187-195.

Research output: Contribution to journalArticle

@article{e907fbc8414d4ff298d4b301cbe4244b,
title = "New anticoagulant and antiplatelet agents: A primer for the gastroenterologist",
abstract = "A large number of patients worldwide receive anticoagulant and antiplatelet agents, collectively known as antithrombotic agents. Several new anticoagulants and antiplatelet agents recently were approved for use. Gastroenterologists may be unfamiliar with the mechanism of action, indications for use, and pharmacokinetics of these newer drugs. In patients undergoing elective and urgent endoscopic procedures, clinicians must be familiar with these medications to optimize outcomes. When the decision is made to continue the newer antithrombotic agents for elective procedures, the clinician must understand the risk that these agents may impart on procedural-induced bleeding. Finally, it is important to understand how to manage these agents in the presence of acute gastrointestinal bleeding. In this article the use of newer antithrombotic agents is reviewed.",
keywords = "Anticoagulants/Administration and dosage, Atrial fibrillation, Drug administration schedule, Drug monitoring, Endoscopy, Gastrointestinal, Thrombosis/Drug therapy",
author = "Baron, {Todd H.} and Kamath, {Patrick Sequeira} and McBane, {Robert D.}",
year = "2014",
month = "2",
doi = "10.1016/j.cgh.2013.05.020",
language = "English (US)",
volume = "12",
pages = "187--195",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - New anticoagulant and antiplatelet agents

T2 - A primer for the gastroenterologist

AU - Baron, Todd H.

AU - Kamath, Patrick Sequeira

AU - McBane, Robert D.

PY - 2014/2

Y1 - 2014/2

N2 - A large number of patients worldwide receive anticoagulant and antiplatelet agents, collectively known as antithrombotic agents. Several new anticoagulants and antiplatelet agents recently were approved for use. Gastroenterologists may be unfamiliar with the mechanism of action, indications for use, and pharmacokinetics of these newer drugs. In patients undergoing elective and urgent endoscopic procedures, clinicians must be familiar with these medications to optimize outcomes. When the decision is made to continue the newer antithrombotic agents for elective procedures, the clinician must understand the risk that these agents may impart on procedural-induced bleeding. Finally, it is important to understand how to manage these agents in the presence of acute gastrointestinal bleeding. In this article the use of newer antithrombotic agents is reviewed.

AB - A large number of patients worldwide receive anticoagulant and antiplatelet agents, collectively known as antithrombotic agents. Several new anticoagulants and antiplatelet agents recently were approved for use. Gastroenterologists may be unfamiliar with the mechanism of action, indications for use, and pharmacokinetics of these newer drugs. In patients undergoing elective and urgent endoscopic procedures, clinicians must be familiar with these medications to optimize outcomes. When the decision is made to continue the newer antithrombotic agents for elective procedures, the clinician must understand the risk that these agents may impart on procedural-induced bleeding. Finally, it is important to understand how to manage these agents in the presence of acute gastrointestinal bleeding. In this article the use of newer antithrombotic agents is reviewed.

KW - Anticoagulants/Administration and dosage

KW - Atrial fibrillation

KW - Drug administration schedule

KW - Drug monitoring

KW - Endoscopy

KW - Gastrointestinal

KW - Thrombosis/Drug therapy

UR - http://www.scopus.com/inward/record.url?scp=84892488760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892488760&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2013.05.020

DO - 10.1016/j.cgh.2013.05.020

M3 - Article

C2 - 23735447

AN - SCOPUS:84892488760

VL - 12

SP - 187

EP - 195

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 2

ER -